Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
18 studies found for:    Open Studies | "Supranuclear Palsy, Progressive"
Show Display Options
Rank Status Study
1 Not yet recruiting A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Interventions: Drug: ABBV-8E12;   Drug: Placebo
2 Recruiting Young Plasma Transfusions for Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Intervention: Other: Fresh Frozen Plasma
3 Recruiting A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Intervention: Drug: F-18 AV 1451
4 Recruiting A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Intervention: Drug: Salsalate
5 Recruiting Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy (PSP)
Interventions: Drug: Rivastigmine;   Drug: Placebo
6 Recruiting Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy.
Conditions: Idiopathic Parkinson's Disease;   Progressive Supranuclear Palsy
Intervention: Device: Foot Mechanical Stimulation (GONDOLA)
7 Recruiting PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
Conditions: Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration;   Multiple System Atrophy (MSA)
Intervention:
8 Recruiting Study of the Neural Basis of Analogical Reasoning
Conditions: Frontotemporal Dementia;   Progressive Supranuclear Palsy;   Healthy Subjects
Interventions: Device: transcranial magnetic stimulation;   Other: MRI imaging;   Other: EEG recording;   Behavioral: Neuropsychological examination
9 Recruiting Biomarkers in Parkinsonian Syndromes
Conditions: Parkinsonian Syndromes;   Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
Interventions: Other: CSF, blood and urine sampling;   Other: clinical measures of disease severity and progression
10 Recruiting Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies
Conditions: Alzheimer's Disease (AD);   Progressive Supranuclear Palsy (PSP);   Cortical Basal Syndrome (CBS);   Frontal Temporal Dementia (FTD)
Intervention: Drug: [18F]MNI-815 (MNI-815)
11 Recruiting Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes
Conditions: Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy;   Vascular Parkinsonism
Intervention: Other: MRI exam of the brain
12 Recruiting Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
Conditions: Parkinson's Disease (PD);   Parkinsonism;   Progressive Supranuclear Palsy (PSP);   Multiple System Atrophy (MSA)
Intervention:
13 Recruiting 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
Conditions: Corticobasal Degeneration (CBD);   Corticobasal Syndrome (CBS);   Cortical-basal Ganglionic Degeneration (CBGD);   Progressive Supranuclear Palsy (PSP);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)
Intervention: Other: Observational Study
14 Recruiting Diagnosing Frontotemporal Lobar Degeneration
Conditions: Corticobasal Syndrome;   Progressive Supranuclear Palsy;   Behavioral Variant Frontotemporal Dementia;   Semantic Dementia;   Progressive Nonfluent Aphasia;   Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia
Intervention: Other: Observational Study
15 Recruiting Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
Conditions: Alzheimer's Disease (AD);   Parkinson's Disease (PD);   Chronic Traumatic Encephalopathy (CTE);   Progressive Supranuclear Palsy (PSP);   Frontal Temporal Dementia (FTD);   Pick's Disease;   Tauopathies
Intervention: Drug: [18F]T807 ([18F]MNI-777)
16 Not yet recruiting Unique Brainstem Biomarkers of Early Parkinson's Disease
Conditions: Parkinson's Disease;   Alzheimer's Disease;   Progressive Supranuclear Palsy;   Essential Tremor;   Multiple System Atrophy;   Drug Induced Parkinson's Disease;   Diffuse Lewy Body Disease;   Myasthenia Gravis
Interventions: Other: Electrical Brainstem Responses;   Other: Olfactory Tests;   Other: Visual Deprivation
17 Recruiting Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Conditions: FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
Intervention:
18 Not yet recruiting Vaccination Uptake (VAX) in PD
Condition: Parkinson's Disease
Interventions: Behavioral: Standard of Care;   Behavioral: Home Visit Program (HVP)

Study has passed its completion date and status has not been verified in more than two years.